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Influence of ethanol on the myorelaxant effect
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Interaction of ethanol with benzodiazepines can lead to
enhanced therapeutic anxyolytic, sedative and hypnotic
effects but can also augment unwanted effects such as
drowsiness, confusion, amnesia and impaired coordina-
tion. In this study we investigated the interaction be-
tween ethanol and diazepam and its influence on muscle
strength in rats using the grip-strength meter. Three do-
ses of ethanol (0.4, 0.6 and 0.8 g kg–1 of body mass) and
diazepam (0.75, 1.5 and 7.5 mg kg–1 b.m.) were used in
experiments. Single substances and their combinations
were tested. The myorelaxant effect of ethanol, measured
as grip force (expressed in grams), was dose-dependent.
The lowest dose (0.4 g kg–1 b.m.) failed to affect muscle
strength while the strongest effect was observed with the
highest dose of ethanol (0.8 g kg–1 b.m.) and it lasted for 75
min. Diazepam dose-dependently reduced muscle strength
too. However, when ethanol was combined with diaze-
pam (1.5 mg kg–1 b.m.), more enhanced muscle relax-
ation occurred than by either drug alone. Namely, two
lower doses of ethanol (0.4 and 0.6 g kg–1 b.m) enhanced
the myorelaxant effect of diazepam by additional 26 and
46%, respectively, when measured after 15 min. The most
pronounced myorelaxation was recorded when the highest
dose of ethanol (0.8 g kg–1 b.m.) was combined with di-
azepam: from complete muscle relaxation observed after
15 min, it gradually decreased to 91% at the 45th min
and to 24% at the 105th min after the beginning of the
treatment.
The results of this preclinical investigation showed that
ethanol enhanced the muscle relaxant effect of diazepam
in rats. This enhancement as well as duration of the ef-
fect was dependent on the applied dose of ethanol.
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Acute ingestion of ethanol combined with benzodiazepines is widespread and is re-
sponsible for several toxicological interactions, which can have significant clinical impli-
cations. Ethanol is used as a social »drug« and is legal and freely available. However, it
could be very dangerous, especially because of its ability to influence the pharmacokine-
tics or pharmacodynamics of many prescribed and over-the-counter therapeutic agents,
for example, benzodiazepines, barbiturates, some antidepressants, antipsychotics, anal-
getics, antibiotics. These interactions can lead to a changed therapeutic effect because eth-
anol can influence absorption and metabolism or interfere with the drug at its site of ac-
tion. However, the results of interactions between ethanol and therapeutic agents depend
on the amount and duration of alcohol consumption (acute or chronic alcohol intake) (1).
On the other hand, benzodiazepines are extensively used in the pharmacotherapy
of anxiety disorders and sleep disturbances throughout the world. In addition to anxio-
lytic, sedative and hypnotic effects, benzodiazepines, especially diazepam, have a well
documented and therapeutically valuable myorelaxant effect. Therefore, diazepam is used
to treat chronic muscle spasms, such as example chronic back pain and spasticity result-
ing from birth injury, cerebral vascular disease, or spinal cord lesions. Benzodiazepines
reduce the muscle tone by central action that is independent of their sedative effect. The
drugs reduce the background tone of the muscle without seriously affecting its ability to
contract transiently under voluntary control (2). Clinical applicability of this class of drugs
is limited in distressed patients with a current or prior history of alcoholism. However,
combined use of anxiolytics and ethanol is widespread and well documented (3). Acute
ingestion of alcohol combined with benzodiazepines, especially diazepam as one of the
commonly prescribed benzodiazepine, is responsible for several toxicological interac-
tions that can have significant clinical implications. Fatal poisoning involving coadminis-
tration of these substances continues to be a serious problem (4). Unfortunately, benzo-
diazepines are often prescribed without adequate information concerning the patient’s
ethanol use. It should be stressed that ethanol is able to enhance myorelaxation and im-
pair coordination, especially if combined with other central nervous system depressants,
which considerably affects manual skills and also driving performance.
Therefore, in the present study we investigated the intensity of the myorelaxant ef-
fect of acutely administered different doses of diazepam and ethanol alone in rats using
the grip-strength meter. Further, the dose- and time-dependence of ethanol’s influence
on myorelaxant action of diazepam, when used concomitantly, was investigated. The em-
ployed doses of these substances were chosen to be lower than the doses commonly used
in other preclinical experiments. Namely, the aim of the present study was to find the
lowest dose of ethanol that could significanty enhance the myorelaxant effect of diazepam.
EXPERIMENTAL
Animals
The experiments involved female Wistar rats, approximately three months old and
weighing about 180  10 g, under standard laboratory conditions (temperature 22 °C
with changes of light and dark every 12 hours and constant access to food and water).
The rats were divided into 9 groups, 5–7 animals in each group.
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Tested substances
Diazepam solution (Normabel ampoules, Belupo, Croatia) was diluted in 0.9%
NaCl. Diazepam (0.75, 1.5 and 7.5 mg kg–1 b.m.) was injected intraperitoneally in a vol-
ume of 0.5 mL. Three doses of ethanol were used: 0.4, 0.6 and 0.8 g kg–1 b.m. These were
administered intraperitoneally as 0.5, 0.75 or 1 mL of 15% (V/V) solution per animal, re-
spectively.
Each rat within a treated group received a single dose of diazepam or ethanol 15
min before measurement. In combined treatments, diazepam was applied 5 min before
ethanol. The same animals were used for control measurements and received 0.5 mL sa-
line only.
Method
Muscle strength was measured using the grip-strength meter method (Ugo Basile,
Italy). The apparatus measures the pull force (expressed in grams) necessary to overco-
me the animal's forelimbs grip-strength to the bar connected to a force transducer. This
forelimb grip-strength procedure is accepted as a useful screening test for identification
of the potential muscle relaxant properties of drugs (5). The animal is placed over a pla-
te, in front of a grasping trapeze, which is the arm of a force transducer connected to the
peak amplifier. When pulled by the tail, the animal grasps the trapeze. Namely, rodents
instinctively grab anything they can to try to stop this involuntary backward movement.
After the animal loses its grip on the grasping trapeze, the peak preamplifier automati-
cally stores the peak pull force achieved by the forelimbs and shows it on the liquid cry-
stal display. Control values for each group of animals were obtained measuring the grip
force before treatments with the tested substances.
In the present study, measurements of muscle strength started 15 min after the last
intraperitoneal application of tested substances and lasted until complete recovery of
muscle strength.
Statistical analysis
Results are presented as mean  SE. Significance of the difference between the re-
sults was determined using the Newman-Keuls test for independent groups. Difference
between means was considered significant at p < 0.05.
RESULTS AND DISCUSSION
The rodent grip-strength test, employed in this study, represents a useful screening
test for identification of the potential muscle relaxant properties of different substances
(6). Also, the effects of drugs, toxins, diseases, ageing or neural damage may be assessed
using this test.
The present experiments in rats, involving the grip-strength test, showed that myo-
relaxant effect of ethanol alone was dose- and time-dependent. The strongest response
was obtained with the dose of 0.8 g kg–1 b.m. and lasted for 75 min. The maximal reduc-
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tion of the pull force was 56%. While the medium dose of ethanol (0.6 g kg–1 b.m.) signi-
ficantly changed muscle strength after the first 15 min, the lowest dose (0.4 g kg–1 b.m.)
failed to affect the grip force (Table I).
Some previous studies have shown the importance of both dose and time depend-
ency on ethanol action. Thus, Durcan and Lister (7) found that the effects of ethanol (1.2
g kg–1 b.m.) on the behaviour of mice on the holeboard and the plus-maze, as models to
investigate exploratory and locomotor behaviours, vary with the dose and time of ad-
ministration of ethanol and these changes do not always follow the same pattern.
The muscle relaxant effect of diazepam was also dose- and time-dependent. The
strongest effect was obtained with the dose of 7.5 mg kg–1 b.m. while the lowest used
dose (0.75 mg kg–1 b.m.) did not significantly change the animal’s muscle strength (Ta-
ble II). The mean pull force with the highest dose was reduced by about 80% when mea-
sured 15 min following the drug administration while in the 75th min a 58% reduction
was obtained.
The percent change of grip-force measured before and after the treatment with tested
substances is presented in Fig. 1. In combined treatments, the influence of different do-
ses of ethanol on intensity of the muscle relaxant effect of diazepam was investigated.
Since the highest dose of diazepam (7.5 mg kg–1 b.m.) produced robust myorelaxation
when applied alone, the dose of diazepam whose effect was evident but less pronoun-
ced was chosen; therefore, for combined treatments, diazepam in the dose of 1.5 mg kg–1
b.m. was used.
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Table I. Time profile of the myorelaxant effect of ethanol
Ethanol dose
(g kg–1 b.m.)
Grip strength (g) after the application of ethanol (min)a
0 15 45 75 105
0.4 364.2  8.6 346.5  20.5 385  20.8 370.3  15.3 NM
0.6 360.3  16.2 277.1  32.1b 348  23.7 363.7  23.9 NM
0.8 354.6  18.4 160.7  8.3c 217.3  17.2c 298.3  7.2b 328.8  12.2
NM – not measured.
a Mean  SE, n = 5–7.
Statistically significant differences compared to the control (t = 0): b p < 0.05, c p < 0.001.
Table II. Time profile of the myorelaxant effect of diazepam
Diazepam dose
(mg kg–1 b.m.)
Grip strength (g) after the application of diazepam (min)a
0 15 45 75 105
0.75 353.2  8.6 356.5  18.5 365.7  21.8 NM NM
1.5 334.9  14.2 170.1  22.1c 222.5  19.7b 271.7  18.9 314.8  15.6
7.5 364.9  6.2 75.4  8.3c 106.5  11.2c 152.3  17.2c 305.4  12.2
a NM – not measured.
Mean  SE, n = 5–7.
Statistically significant difference compared to the control (t = 0): b p < 0.05, c p < 0.001.
When diazepam in the dose of 1.5 mg kg–1 b.m. was applied concomitantly with
each of the three doses of ethanol, a significantly augmented myorelaxant effect was ob-
tained in rats. This enhancement of muscle relaxation depended on the ethanol emplo-
yed dose (Table III). Thus, a significantly increased muscle relaxant effect was observed
for combinations of diazepam (1.5 mg kg–1 b.m.) with ethanol at the doses of 0.4 and 0.6
g kg–1 b.m., especially in the first 15 min (p < 0.01, compared to diazepam and ethanol
alone, respectively). For example, these doses of ethanol enhanced the muscle relaxant
effect of diazepam by additional 26% and 45%, respectively, after the first 15 min. Com-
bination of diazepam and ethanol of 0.8 g kg–1 b.m. produced a more robust myorelaxant
effect, which lasted longer than the effect of either substance alone. Namely, complete
muscle relaxation was observed after 15 min of experiment and it decreased to 91% in the
45th min and to 24% in the 105th min after the beginning of combined treatment (Fig. 1).
Since combined use of ethanol and benzodiazepines represents a major problem in
practice, there are many preclinical as well as clinical investigations dealing with all as-
pects of this potentially fatal interaction. Some recent studies investigated benzodiaze-
pines-induced impairment of motor performance using the rat rotarod model (8), mice
horizontal wire task (9) or radiotelemetric method to test electromyografic activity in ani-
mals (10). When ethanol was combined with different benzodiazepines and with non-
benzodiazepine, zolpidem, a marked augmentation of the effects of these drugs was ob-
tained. However, doses of ethanol used in these studies were higher (above 1 g kg–1 b.m.)
than the doses employed in the present study.
Although ethanol is supposed to act non-specifically as a general central nervous
system (CNS) depressant, several cellular mechanisms of its action are postulated, such
as inhibition of calcium-channel opening, inhibition of N-methyl-D-aspartate (NMDA)
type glutamate receptors and enhancement of gamma-aminobutyric acid (GABA) action
(2). The last mechanism is common to ethanol and benzodiazepines; namely, both sub-
stances act as agonists of GABA type A (GABA-A) receptors. These receptors are ligand-
-gated chloride channels that mediate inhibitory synaptic transmission in CNS. Diaze-
pam acts by binding to a specific regulatory site on the GABA-A receptor, thus enhanc-
119































Fig. 1. Time profile of the combined myo-
relaxant effect of diazepam (1.5 mg kg–1
b.m.) and ethanol.
ing the effect of GABA in CNS. However, subtypes of GABA-A receptor exist in different
brain regions and differ in their sensitivity to various benzodiazepines (11). Ethanol en-
hances the action of GABA on GABA-A receptors in a similar way as do benzodiaze-
pines. Its action is, however, weaker and less consistent and no obvious effect on inhibi-
tory synaptic transmission in the CNS has been demonstrated for ethanol.
Recent studies have clearly demonstrated that GABA-A receptors play an important
role in ethanol dependence, and functional properties of these receptors are altered fol-
lowing chronic ethanol administration (12). A recent study in humans tested the acute
behavioural effects of two benzodiazepines, triazolam and temazepam, alone and in
combination with a moderate dose of ethanol (0.5 g kg–1 b.m.), which corresponds to 2–3
standard drinks (a single drink usually contains about 8–12 g of ethanol). These results
showed that ethanol alone caused little performance impairment, while its combination
with benzodiazepines produced robust performance impairment that might diminish an
individual’s ability to respond adequately to unexpected demands (13).
The results of the present study are in agreement with the preclinical as well as clini-
cal investigations, which showed more pronounced effects when benzodiazepine was com-
bined with ethanol. Since some of the goals of our experiments were to find the lowest
dose of ethanol that could affect significantly the muscle relaxant effect of diazepam as
well as to investigate the dose and time-dependence of this interaction, we used much lo-
wer doses of both substances, compared to those usually used in preclinical investigations.
Therefore, the present preclinical study investigating myorelaxant effects of ethanol
and diazepam separately or concomitantly showed that: (i) the effects of both ethanol
and diazepam were dose- and time-dependent; (ii) when applied concomitantly, ethanol
enhanced significantly the muscle relaxant effect of diazepam in the dose-dependent
and time-dependent manner. This effect lasted longer in combined treatment than with
either substance alone; (iii) ethanol's ability to enhance the myorelaxant effect of diaze-
pam is evident even at doses as low as 0.4 g kg–1 b.m. in rats.
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Table III. Time profile of the combined myorelaxant effect of diazepam and ethanol
Combined treatment
Grip strength (g) after the application of substances (min)a
0 15 45 75 105
Diazepam
(1.5 mg kg–1 b.m.) +
ethanol (0.4 g kg–1 b.m.)
354  18 85.9  23.3c 206.6  21.3b 318.8 ± 14.1 325 ± 20.8
Diazepam
(1.5 mg kg–1 b.m.) +
ethanol (0.6 g kg–1 b.m.)
364.2  16.7 16.6  10.3c 132.5  19.7c 253.8  14.7b 301  31.3
Diazepam
(1.5 mg kg–1 b.m.) +
ethanol (0.8 g kg–1 b.m.)
352.6  19 0c 33.4  8.4c 220.7  19c 268.5  16.9b
a Mean ± SE, n = 5–7.
Statistically significant difference compared to the control (t = 0): b p < 0.05, c p < 0.001.
CONCLUSIONS
The marked enhancement of diazepam-induced muscle relaxation by ethanol, ob-
served in the present investigation, confirmed the great danger in practice of the interac-
tion between these two substances, not only because of an enhanced CNS depressant ef-
fect, but also because of impaired muscle activity which could affect work and motor
performance.
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S A @ E T A K
Utjecaj etanola na miorelaksiraju}e djelovanje diazepama u {takora
LIDIJA BACH-ROJECKY i ITA SAMAR@IJA
Konzumacija etanola mo`e dovesti do poja~anog anksioliti~kog, sedativnog i hip-
notskog djelovanja benzodiazepina, a mo`e i poja~ati njihove ne`eljene reakcije, kao {to
su vrtoglavica, konfuzija, amnezija i poreme}ena koordinacija. Cilj ovog rada bio je ispi-
tati miorelaksiraju}i u~inak diazepama i etanola kod {takora koriste}i »metodu ja~ine
stiska«. Tako|er se `eljelo utvrditi u kojoj dozi te u kolikoj mjeri primjena etanola mo`e
poja~ati djelovanja diazepama. Stoga su u ispitivanjima kori{tene po tri doze etanola
(0,4, 0,6 and 0,8 g kg–1 tjelesne mase, t.m.) i diazepama (0,75, 1,5 and 7,5 mg kg–1 t.m.).
Miorelaksiraju}e je djelovanje ispitivano nakon jednokratne primjene obje supstance po-
jedina~no kao i u njihovoj kombinaciji. Miorelaksiraju}i u~inak etanola kao i diazepama
pojedina~no bio je ovisan o dozi. [to je doza bila ve}a, to je u~inak bio ja~i, a vrijeme
njegova trajanja bilo je dulje. Kod istodobne primjene diazepama (1,5 mg kg–1 t.m.) s
razli~itim dozama etanola, miorelaksiraju}e se djelovanje zna~ajno poja~alo i produljilo
u odnosu na ispitivane supstance pojedina~no. Pritom je u~inak bio najja~e izra`en u pr-
vih 15 min, a potom je postupno slabio. Naime, u tom je vremenu najmanja doza etanola
kori{tena u ovom radu poja~ala miorelaksiraju}e djelovanje diazepama za dodatnih 26%,
srednja za ~ak 46% dok je u kombinaciji s najve}om dozom etanola nastupila potpuna
mi{i}na relaksacija koja je postupno, tijekom vremena, slabila da bi 105 min nakon prim-
jene supstancija iznosila oko 24%.
Stoga rezultati ovog pretklini~kog ispitivanja pokazuju da etanol, ovisno o dozi, po-
ja~ava miorelaksiraju}e djelovanje diazepama kod eksperimentalnih `ivotinja. Ono je
trajalo dulje {to je doza etanola u kombinaciji s diazepamom bila ve}a.
Klju~ne rije~i: diazepam, etanol, interakcija, mi{i}na snaga
Farmaceutsko-biokemijski fakultet, Zagreb
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